No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

South Korea’s Metaverse Doctors Alliance to Adopt SOLVE Token as Payment Currency in the Healthcare Metaverse

Editor: What To Know

  • Care, the healthcare relationship management platform company, has today made a landmark announcement with the Metaverse Doctors Alliance (MDA), a Korean professional organization made up of leading healthcare professionals to promote the use of the metaverse for healthcare.
  • In a country where telemedicine is still very tightly controlled, with temporary limited relaxations under emergency COVID measures, the metaverse is positioned as virtual in-person healthcare consultations to overcome the restrictive telemedicine laws in the country.
  • The SOLVE token was designed to play an integral part in streamlining healthcare payments, and this announcement is a testament to the utility of our token.

Solve.Care, the healthcare relationship management platform company, has today made a landmark announcement with the Metaverse Doctors Alliance (MDA), a Korean professional organization made up of leading healthcare professionals to promote the use of the metaverse for healthcare.

Under this agreement, the SOLVE token will be adopted as the payment currency of choice for healthcare services rendered in South Korea’s upcoming Metaverse Clinic.

This announcement was made as part of Solve.Care CEO, Pradeep Goel’s visit to South Korea during a signing ceremony with the MDA.  Users of the country’s first metaverse healthcare clinic will pay for all services using the Solve.Care’s Care.Wallet, the company’s personal healthcare management app, with SOLVE tokens as the currency. In addition to this, Solve.Care has been appointed as the official blockchain advisors to the MDA.

Commenting on the announcement, Solve.Care CEO Pradeep Goel said, “I am full of admiration for the visionary sight that the MDA possesses. I am also very honored and proud that the MDA has chosen Solve.Care to be their blockchain advisors. The SOLVE token was designed to play an integral part in streamlining healthcare payments, and this announcement is a testament to the utility of our token. I look very much forward to working even more closely with the MDA, and the upcoming launch of the Metaverse Clinic next year.”

Speaking on behalf of the MDA, Yoseup Kim said, “The metaverse represents a new realm of possibilities for the advancement of healthcare for the general public. We are seeking to create a new healthcare system, not just for Korea, but for the world. We are only limited by our own imagination, and that is why the MDA is actively seeking to work with global companies who understand what the Fourth Industrial Revolution can bring and who are healthcare experts as well. It is for this reason we have chosen to work with Solve.Care, a company with a proven track record of launching blockchain solutions for healthcare.”

In a country where telemedicine is still very tightly controlled, with temporary limited relaxations under emergency COVID measures, the metaverse is positioned as virtual in-person healthcare consultations to overcome the restrictive telemedicine laws in the country. The MDA hopes to launch the country’s first metaverse healthcare clinic in the first quarter of 2023.

This news comes off the back of the company’s recent appointment of Dr. Uhn Lee, a leading neurosurgeon and Professor at Gachon University, Gil Hospital as the President of Solve.Care Korea.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy